找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Innovation in Life Sciences; The Digital Revoluti Avo Schönbohm,Hans Henning von Horsten,Moritz von Book 2024 The Editor(s) (if applicable

[复制链接]
查看: 35646|回复: 55
发表于 2025-3-21 20:05:15 | 显示全部楼层 |阅读模式
书目名称Innovation in Life Sciences
副标题The Digital Revoluti
编辑Avo Schönbohm,Hans Henning von Horsten,Moritz von
视频video
概述Presents interdisciplinary insights into the digitalisation of the life science industry.Includes in-depth case studies of digital disruption.Discusses future business models for digital healthcare
丛书名称Management for Professionals
图书封面Titlebook: Innovation in Life Sciences; The Digital Revoluti Avo Schönbohm,Hans Henning von Horsten,Moritz von  Book 2024 The Editor(s) (if applicable
描述The Life Science industry has been subject to a digital revolution upending all facets of the value chain with data-driven approaches like Gene Therapy, Personalized Medicine, Advanced Cell and Tissue Engineering, Industry 4.0, Artificial Intelligence, Blockchain, Digital Twins, Internet-of-Medical-Things (IoMT) and Software-as-a-Medical-Device (SaMD). Our edited volume offers comprehensive coverage of the digital disruption sweeping through the industry. From drug discovery to manufacturing and life-cycle management, we explore the profound impact of digitalization. Our authors delve into open innovation, sci-fi prototyping, and the digital transformation of medical imaging and healthcare. This volume goes beyond theory to provide practical insights. We present business-oriented case studies, examine M&A topics, venture capital, and other investor perspectives, all with a strong focus on digitalization‘s role. Furthermore, we explore the cultural and ethical challenges that arise andthe necessary management changes demanded by this digital revolution..
出版日期Book 2024
关键词Life Science; Digitalization; Technological innovation; Health sector; AI; Diagnostic imaging; Personalise
版次1
doihttps://doi.org/10.1007/978-3-031-47768-3
isbn_softcover978-3-031-47770-6
isbn_ebook978-3-031-47768-3Series ISSN 2192-8096 Series E-ISSN 2192-810X
issn_series 2192-8096
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

书目名称Innovation in Life Sciences影响因子(影响力)




书目名称Innovation in Life Sciences影响因子(影响力)学科排名




书目名称Innovation in Life Sciences网络公开度




书目名称Innovation in Life Sciences网络公开度学科排名




书目名称Innovation in Life Sciences被引频次




书目名称Innovation in Life Sciences被引频次学科排名




书目名称Innovation in Life Sciences年度引用




书目名称Innovation in Life Sciences年度引用学科排名




书目名称Innovation in Life Sciences读者反馈




书目名称Innovation in Life Sciences读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-22 00:07:46 | 显示全部楼层
Management for Professionalshttp://image.papertrans.cn/i/image/466829.jpg
发表于 2025-3-22 02:49:28 | 显示全部楼层
https://doi.org/10.1007/978-3-031-47768-3Life Science; Digitalization; Technological innovation; Health sector; AI; Diagnostic imaging; Personalise
发表于 2025-3-22 07:50:07 | 显示全部楼层
978-3-031-47770-6The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
发表于 2025-3-22 12:00:53 | 显示全部楼层
发表于 2025-3-22 13:48:45 | 显示全部楼层
Dancing with Biopunks: Innovation in the Life Science Industry and Science Fictions. We apply science fiction for inspiration and reflection of life science innovators in a dialectical way between biopunk and solarpunk. Starting with the dystopian biopunk genre, we exemplify various trends and patterns from a critical perspective on the life sciences, focusing on bioengineering a
发表于 2025-3-22 18:38:23 | 显示全部楼层
发表于 2025-3-22 21:48:32 | 显示全部楼层
Digitally Enhanced Life Cycle Management for a Blockbuster Prescription Drugg enjoys patent protection..Among many other factors, LCM decisions ought to consider technology changes that affect diagnostic or clinical pathways in indications covered by the approved pharmaceutical drug..The current paper discusses an Investigator Sponsored Research (ISR) activity financially s
发表于 2025-3-23 03:41:26 | 显示全部楼层
发表于 2025-3-23 06:21:01 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-16 02:12
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表